Neurobehavioral Disorders
For this study, community-dwelling adults were evaluated for major depressive disorder, generalized anxiety disorder, and global sleep quality over an 18 year period.
Neurobehavioral Disorders
Investigators sourced data from the Norwegian Mother, Father and Child Cohort Study which was a population-based pregnancy cohort study conducted between 1999 and 2008.
Neurobehavioral Disorders
Inpatients with persistent depressive disorder were recruited at a German University Hospital for a 10-week inpatient treatment with the Cognitive Behavioral Analysis System of Psychotherapy.
Neurobehavioral Disorders
This observational study was conducted by telephone interviews between April and July 2020.
Neurobehavioral Disorders
The Cantabria Early Intervention in Psychosis Program (PAFIP) was conducted between 2012 and 2018 in Spain.
Neurobehavioral Disorders
Patients with somatoform disorders, major depressive disorder, and healthy controls were recruited between 2016 and 2017 at the Ambulante Psychosoziale Rehabilitation in Austria and Schoen Clinic Roseneck in Germany.
Neurobehavioral Disorders
For this study, patients with generalized anxiety disorder were recruited from the Nanfang Hospital in China between 2018 and 2020.
Neurobehavioral Disorders
In a randomized clinical trial, researchers observed the efficacy of escitalopram compared with exercise training and placebo in reducing anxiety in patients with CHD.
Neurobehavioral Disorders
Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.
Neurobehavioral Disorders
Patients with treatment-resistant major depressive disorder or bipolar disorder without psychotic symptoms received intravenous infusions of 0.5 mg/kg ketamine 3 times per week for 2 weeks.